Research programme: cannabinoid CB2 receptor agonists - AbbVieAlternative Names: A-796260
Latest Information Update: 22 Jan 2013
At a glance
- Originator Abbott Laboratories
- Class Indoles; Morpholines; Small molecules
- Mechanism of Action Cannabinoid receptor CB2 agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Preclinical Pain